seed
Stage
1
Investors
About
Trisol Medical develops a transcatheter tricuspid valve replacement (TTVR) device. Its valve features a nitinol frame with sail-like leaflets intended to treat tricuspid regurgitation and associated right ventricular dysfunction.
Explore Trisol Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.